COMPANY PROFILE / #604
Inceptive
Palo Alto, CAVenture Capital-Backed
OVERVIEW
Developer of a biological development platform designed to create synthetic molecules for complex biological functions. The company's platform utilizes artificial intelligence and deep learning technologies to design novel medicines and biotechnologies that facilitate molecular modeling and RNA therapeutics, enabling clients to get advancements in healthcare and biotechnology that were previously unattainable.
已融资120.00
最新估值500.00
员工数40
成立年份2021
公司概况
- Companies
- Inceptive
- Description
- Developer of a biological development platform designed to create synthetic molecules for complex biological functions. The company's platform utilizes artificial intelligence and deep learning technologies to design novel medicines and biotechnologies that facilitate molecular modeling and RNA therapeutics, enabling clients to get advancements in healthcare and biotechnology that were previously unattainable.
- Website
- —
- HQ Location
- Palo Alto, CA
- Year Founded
- 2021
- Keywords
- ai model tools, biotechnology research, drug development firm, gene therapy, modeling tools, molecular modeling analysis, molecular modeling platform, rna therapeutics
- Competitors
- Cyrus Biotechnology, Anima Biotech, Exscientia, Verge Analytics, 20n Bio, X-37, Numerate, Sygnature Discovery, BPS Bioscience, Molecular Assemblies, Metrum Research Group, Genesis Molecular AI, Relay Therapeutics, AbCellera Biologics, Atomic AI, Novo-Informatics, Chemical Computing Group, Personalis, Cyclica, Quark Pharmaceuticals, Lysosomal Therapeutics, Cloud Pharmaceuticals, Haystack Sciences, DyNAbind, Crown Bioscience, Eikon Therapeutics, Owkin, NuMedii, Twist Bioscience, XtalPi Technology, Alector
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 120.00
- First Financing Date
- 17-Dec-2021
- First Financing Size
- 20.00
- First Financing Valuation
- 100.00
- Last Financing Date
- 06-Sep-2023
- Last Financing Deal Type
- Early Stage VC
- Last Financing Size
- —
- Last Financing Valuation
- 500.00
- Last Financing Status
- —
- Last Known Valuation
- 500.00
- Last Known Valuation Date
- 06-Sep-2023
- Last Known Valuation Deal Type
- Early Stage VC
- Valuation Estimate
- —
- Valuation Estimate Growth Rate
- 73.26%
- Active Investors
- Andreessen Horowitz, ARTIS (San Francisco), NVentures (Santa Clara), Obvious Ventures, S32
- # Active Investors
- —
- Acquirers
- —
团队与联系人
- Employees
- 40
- Employee Growth %
- —
- Employee History
- 2023: 40, 2022: 12
- Primary Contact
- Jakob Uszkoreit
- Primary Contact Title
- Co-Founder, Chief Executive Officer & Board Member
- Primary Contact Email
- juszkoreit@inceptive.life
- Primary Contact Phone
- +1 (650) 507-4490
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- —
- Growth Rate % Change
- —
- Growth Rate Percentile
- —
- Size Multiple
- —
- Size Multiple % Change
- —
- Size Multiple Change
- —
- Size Multiple Percentile
- —
- Majestic Referring Domains
- —
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 14%
- Success Probability Over Time – 3 Year
- 31%
- Success Probability Over Time – 5 Year
- 45%
记录来源：public.companies · 原始序号 #604 · 所有字段均按数据库原值展示。